Molecules / Ifosfamide

Ifosfamide API manufacturers

CAS 3778-73-2 ATC L01AA06 Updated 9 July 2026
4
manufacturers with an active filing 4 of them hold a US DMF or a CEP
10
shortage records on file across 5 countries
129
finished-dose makers across 44 regulators
Showing 4 of 4 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Jiangsu Hengrui Pharmaceuticals

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ifosfamide, filing since 1995. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 8 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
8 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

Aarti Pharmalabs

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ifosfamide, filing since 2009. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2026 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Baxter Healthcare

United States
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ifosfamide, filing since 1979. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 24 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · OAI
GMP recognised in
24 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Ifotam

Poland
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ifosfamide, filing since 2000.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile

1 more manufacturer holds filings for ifosfamide

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Ifotam
Open the full list with a free account

Contract manufacturers (1)

Qilu Pharmaceutical China

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (27)

Fresenius Kabi Ab Sweden HIKMA ITALIA Italy Baxter SA-NV Belgium Glenmark Pharmaceuticals s.r.o Czech Republic Naprod Life Sciences India Teva Israel Baxter Oncology Germany Synapse Pharmatech India Eurofarma Laboratorios Brazil Cipla India Microsules Argentina S A Argentina Pfizer Brasil Ltda Brazil Baxter Hospitalar Ltda Brazil Thymoorgan Pharmazie Germany Gador S A Argentina Accure Labs Pvt.Ltd India Getwell Pharmaceuticals India Korea United Pharm South Korea Menarini Indria Laboratories Indonesia Sinergium Biotech S A Argentina

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map ifosfamide for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Shortages 10 Finished dose 27 Contract mfrs 1